These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers. Gabizon A, Goren D, Fuks Z, Barenholz Y, Dagan A, Meshorer A. Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331 [Abstract] [Full Text] [Related]
4. Mode of binding of adriamycin with sulfatide-containing liposomes. Takano M, Kojima N, Yagi K. Biochem Int; 1988 Jul; 17(1):77-86. PubMed ID: 3190718 [Abstract] [Full Text] [Related]
8. Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody. Konno H, Suzuki H, Tadakuma T, Kumai K, Yasuda T, Kubota T, Ohta S, Nagaike K, Hosokawa S, Ishibiki K. Cancer Res; 1987 Aug 15; 47(16):4471-7. PubMed ID: 2440568 [Abstract] [Full Text] [Related]
9. Antitumor effect of adriamycin entrapped in liposomes conjugated with monoclonal antibody against tumor-associated antigen of bovine leukemia cells. Onuma M, Odawara T, Watarai S, Aida Y, Ochiai K, Syuto B, Matsumoto K, Yasuda T, Fujimoto Y, Izawa H. Jpn J Cancer Res; 1986 Nov 15; 77(11):1161-7. PubMed ID: 3025145 [Abstract] [Full Text] [Related]
11. The effect of adriamycin against a liver metastatic model by encapsulation in liposomes. Yachi K, Suzuki N, Tanaka N, Okada K, Mitsui I, Kawato Y, Komagata Y, Komiyama K, Kikuchi H. Biopharm Drug Dispos; 1996 Nov 15; 17(8):699-715. PubMed ID: 8950048 [Abstract] [Full Text] [Related]
13. Antitumor effects of liposomes containing adriamycin on chemically-induced rat malignant fibrous histiocytoma. Nishida K, Yonemura K, Abe Y, Takagi K. Nihon Seikeigeka Gakkai Zasshi; 1995 May 15; 69(5):322-31. PubMed ID: 7797953 [Abstract] [Full Text] [Related]
14. [Selective hepatic arterial infusion of liposomes containing antitumor agents]. Kumai K, Takahashi T, Tsubouchi T, Yoshino K, Ishibiki K, Abe O. Gan To Kagaku Ryoho; 1985 Oct 15; 12(10):1946-8. PubMed ID: 4051510 [Abstract] [Full Text] [Related]
15. Improvement of pharmacokinetics and antitumor activity against human hepatoma cell line by using adriamycin-entrapped stealth liposomes. Shimizu H, Kumai K, Uyama I, Shibata S, Tagawa T, Nagaike K, Yasuda T, Kitajima M, Tadakuma T. J Surg Oncol; 1996 Jul 15; 62(3):186-93. PubMed ID: 8667626 [Abstract] [Full Text] [Related]
16. Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. van Hoesel QG, Steerenberg PA, Crommelin DJ, van Dijk A, van Oort W, Klein S, Douze JM, de Wildt DJ, Hillen FC. Cancer Res; 1984 Sep 15; 44(9):3698-705. PubMed ID: 6744286 [Abstract] [Full Text] [Related]
17. Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Gabizon A, Dagan A, Goren D, Barenholz Y, Fuks Z. Cancer Res; 1982 Nov 15; 42(11):4734-9. PubMed ID: 7127308 [No Abstract] [Full Text] [Related]
18. [Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein or anti-carcinoembryonic antigen monoclonal antibodies]. Konno H. Nihon Geka Gakkai Zasshi; 1986 Apr 15; 87(4):365-74. PubMed ID: 2423862 [Abstract] [Full Text] [Related]
19. Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats. Parker RJ, Hartman KD, Sieber SM. Cancer Res; 1981 Apr 15; 41(4):1311-7. PubMed ID: 7214320 [Abstract] [Full Text] [Related]
20. Studies on the entrapment and stability of liposomes containing sulfatide from human brain. Chen D, Li QT, Lee KH. Biochem Int; 1992 Oct 15; 28(2):297-304. PubMed ID: 1456951 [Abstract] [Full Text] [Related] Page: [Next] [New Search]